What's New

License-Out

License Agreement Has Been Entered into with Eyestem Research Private Limited

We have executed a non-exclusive license agreement with Eyestem Research Private Limited (Bengaluru, India) for the use of iPS cell-derived retinal pigment epithelium (RPE) cell products for regenerative therapy under the patents on iPS cell related technologies licensed to us by Kyoto University.

Eyestem Research Private Limited

Back to top